Latest Shareholder Equity News

ASX Compliance has formally questioned Rewardle Holdings Limited over delayed disclosures, financial inconsistencies, and governance concerns tied to its investments in Pepper Leaf, Beanhunter, and CloudHolter.

Rhythm Biosciences has obtained a $1 million non-dilutive loan backed by its FY2025 R&D Tax Incentive rebate, aiming to accelerate the commercial rollout of its ColoSTAT® test and expand its geneType™ platform.

Vinyl Group has secured a $1.5 million revolving credit facility from Songtradr and proposed converting historical liabilities into equity, aiming to boost its balance sheet and accelerate growth on its Vinyl.com platform.

I Synergy Group Limited has successfully raised approximately $1 million through a fully underwritten entitlement offer, with robust shareholder participation and full underwriting support.

Opyl Limited has taken a bold step into digital assets by acquiring approximately 2 Bitcoin and securing a $2 million finance facility backed by these holdings, signaling a strategic pivot towards blockchain integration in healthcare technology.

Everest Metals has been accepted into the US Defence Industrial Base Consortium, unlocking strategic collaboration and funding opportunities for its Mt Edon Rubidium Project in Western Australia. This milestone advances Australia’s first commercial rubidium production, addressing critical global supply shortages.

EMVision Medical Devices has secured a $5 million non-dilutive government grant to accelerate global commercialisation of its innovative First Responder portable brain scanner, aimed at revolutionising pre-hospital stroke and brain injury care.

Caravel Minerals has locked in a $15 million loan facility to fund the critical Definitive Feasibility Study for its flagship Caravel Copper Project, advancing the path to development without diluting shareholder equity.

Mirrabooka Investment Limited has successfully closed its $85 million entitlement offer, which was oversubscribed, prompting a scale back of Top-Up Facility applications.

ANZ Group Holdings Limited has updated its interim dividend details, confirming an 83-cent payout per share, partially franked at 70%, payable on July 1, 2025. The bank also outlined its Dividend Reinvestment and Bonus Security Plans with shares priced at AUD 28.89.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

Noxopharm Limited has raised nearly $2.5 million by selling its entire stake in Nyrada Inc, providing non-dilutive capital to advance its HERACLES clinical trial and expand its research pipeline.